- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Elagolix
Total 83 results
-
AbbVieTerminated
-
Sumitomo Pharma Switzerland GmbHRecruitingProstate CancerUnited States
-
Myovant Sciences GmbHCompletedUterine Fibroids | Uterine LeiomyomaUnited States, Italy, Poland, Czechia, Hungary, South Africa, Brazil, Chile
-
Myovant Sciences GmbHCompletedEndometriosis Related PainUnited States, Spain, Hungary, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Poland, Portugal, South Africa, Ukraine
-
Myovant Sciences GmbHCompletedEndometriosis Related PainUnited States, Poland, Australia, Brazil, Chile, Czechia, Georgia, Italy, New Zealand, Romania, Sweden
-
University of ChicagoRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer MetastaticUnited States
-
TakedaCompletedHealthy VolunteersUnited States
-
Myovant Sciences GmbHCompletedUterine Fibroid | Heavy Menstrual BleedingUnited States, Belgium, Czechia, South Africa, Chile, Brazil, Hungary, Poland
-
Myovant Sciences GmbHCompletedUterine Fibroid | Heavy Menstrual BleedingUnited States, Italy, Poland, Brazil, South Africa, United Kingdom
-
University of WashingtonWashington State UniversityNot yet recruiting
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Dana-Farber Cancer InstitutePfizer; Prostate Cancer Foundation; Myovant Sciences GmbHRecruitingProstatic Neoplasms | Prostate CancerUnited States
-
TakedaCompletedHealthy VolunteersUnited Kingdom
-
Hennepin County Medical Center, MinneapolisAstellas Pharma IncUnknown
-
TakedaCompleted
-
TakedaCompleted
-
AbbVie (prior sponsor, Abbott)CompletedUterine Fibroids | Heavy Uterine Bleeding
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Sumitomo Pharma Switzerland GmbHActive, not recruiting
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC... and other conditionsUnited States
-
Myovant Sciences GmbHCompletedUterine Fibroid | Heavy Menstrual BleedingUnited States, Italy, Belgium, Czechia, Hungary, Poland, South Africa, Chile, Brazil
-
Myovant Sciences GmbHCompletedEndometriosisUnited States, Spain, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, Poland, Portugal, South Africa, Ukraine, Australia, Brazil, Chile, Italy, New Zealand, Romania, Georgia
-
Millennium Pharmaceuticals, Inc.CompletedEndometriosis | Prostate Cancer
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Myovant Sciences GmbHRecruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of Defense; Prostate Cancer Foundation; Panbela TherapeuticsRecruitingProstate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGeneRecruitingProstate Cancer | Stage IV Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals AmericaNot yet recruitingProstate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
NRG OncologyNational Cancer Institute (NCI)Recruiting
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States